Abstract:Although heparan sulfate (HS) serves as an initial receptor for the binding of both herpes simplex virus type 1 (HSV-1) and HSV-2 to cell surfaces, the two serotypes differ in epidemiology, cell tropism, and ability to compete for viral receptors in vitro. These observations are not necessarily contradictory and can be explained if the two serotypes recognize different structural features of HS. To compare the specific features of HS important for the binding and infection of HSV-1 and HSV-2, we took advantage of structural similarities between heparin and cell surface HS and compared the abilities of chemically modified heparin compounds to inhibit plaque formation. We found that the antiviral activity of heparin for both serotypes was independent of anticoagulant activity. Moreover, specific negatively charged regions of the polysaccharide, including N sulfations and the carboxyl groups, are key structural features for interactions of both HSV-1 and HSV-2 with cell surfaces since N desulfation or carboxyl reduction abolished heparin's antiviral activity. In contrast, 6-O sulfations and 2-,3-O sulfations are important determinants primarily for HSV- 1 infection. The O-desulfated heparins had little or no inhibitory effect on HSV-1 infection but inhibited HSV-2 infection. Using a series of intertypic recombinant mutant viruses, we found that susceptibility to O-desulfated heparins can be transferred to HSV-1 by the gene for glycoprotein C of HSV-2 (gC-2). This supports the notion that the envelope glycoproteins of HSV-1 and HSV-2 interact with different affinities for different structural features of heparin. To determine if the modified heparin compounds inhibited plaque formation by competing with cell surface HS for viral attachment, binding studies were also performed. As anticipated, most compounds inhibited binding and plaque formation in parallel. However, several compounds inhibited the binding of HSV-1 to cells during the initial attachment period at 4 degrees C; this inhibitory effect was reversed when the cells and inoculum were shifted to 37 degrees C. This temperature-dependent differential response to modified heparin compounds was evident primarily when glycoprotein C of HSV-1 (gC-1) was present in the virion envelope. Minimal temperature-dependent differences were seen for HSV-1 with gC-1 deleted and for HSV-2. These results suggest differences in the interactions of HSV-1 and HSV-2 with cell surface HS that may influence cell tropism.

Archaic connectivity between the sulfated heparan sulfate and the herpesviruses - An evolutionary potential for cross-species interactions

Prediction and Analysis of Human-Herpes Simplex Virus Type 1 Protein-Protein Interactions by Integrating Multiple Methods

Role of dendritic cells in host immunity to herpes simplex virus and possible mechanisms

Molecular determinants of the interaction between HSV-1 glycoprotein D and heparan sulfate

Simplexviruses Successfully Adapt to Their Host by Fine-Tuning Immune Responses

The structural basis of herpesvirus entry

Entry receptor bias in evolutionarily distant HSV-1 clinical strains drives divergent ocular and nervous system pathologies

Receptors and ligands for herpes simplex viruses: Novel insights for drug targeting

A review of HSV pathogenesis, vaccine development, and advanced applications

Effects of two amino acid substitutions in the capsid proteins on the interaction of two cell-adapted PanAsia-1 strains of foot-and-mouth disease virus serotype O with heparan sulfate receptor

Advances in the immunoescape mechanisms exploited by alphaherpesviruses

Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry

Species-Specific Deamidation of Cgas by Herpes Simplex Virus UL37 Protein Facilitates Viral Replication

Herpes Simplex Virus 1 Glycoprotein B from a Hyperfusogenic Virus Mediates Enhanced Cell–Cell Fusion

Role of Heparanase and Syndecan-1 in HSV-1 Release from Infected Cells

Allosteric mechanism of membrane fusion activation in a herpesvirus

Herpes Simplex Virus Cell Entry Mechanisms: An Update

Host heparan sulfate promotes ACE2 super-cluster assembly and enhances SARS-CoV-2-associated syncytium formation

Site-specific sulfations regulate the physicochemical properties of papillomavirus–heparan sulfate interactions for entry

Immunogenetic profiles of 9 human herpes virus envelope glycoproteins

Integrating pan-genome and reverse vaccinology to design multi-epitope vaccine against Herpes simplex virus type-1